Global Reporter Gene Assay Market to Reach $11.5 Billion by 2030
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.
New York, May 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Reporter Gene Assay Industry" - https://www.reportlinker.com/p06032765/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Reporter Gene Assay Market to Reach $11.5 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Reporter Gene Assay estimated at US$7.9 Billion in the year 2022, is projected to reach a revised size of US$11.5 Billion by 2030, growing at aCAGR of 4.8% over the period 2022-2030. Luciferase Assays, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$4.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Fluorescent Protein-Related Assays segment is readjusted to a revised 5.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 4.2% CAGR
The Reporter Gene Assay market in the U.S. is estimated at US$2.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2030 trailing a CAGR of 4.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 3.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.
Select Competitors (Total 32 Featured)
- Abcam PLC
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Biotium
- Danaher Corporation
- Genecopoeia, Inc.
- Geno Technology, Inc.
- Invivogen
- Merck KGaA
- Perkinelmer
- Promega Corporation
- Promocell
- Thermo Fisher Scientific, Inc.
Read the full report: https://www.reportlinker.com/p06032765/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Reporter Gene Assay - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Reporter Gene Assay by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 2: World 8-Year Perspective for Reporter Gene Assay by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2023 & 2030
Table 3: World Recent Past, Current & Future Analysis for
Academic & Research Institutes by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 4: World 8-Year Perspective for Academic & Research
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2023 & 2030
Table 5: World Reporter Gene Assay Market Analysis of Annual
Sales in US$ Million for Years 2014 through 2030
Table 6: World Recent Past, Current & Future Analysis for
Contract Research Organizations (CROs) by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 7: World 8-Year Perspective for Contract Research
Organizations (CROs) by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2023 & 2030
Table 8: World Recent Past, Current & Future Analysis for
Hospital & Diagnostic Laboratories by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 9: World 8-Year Perspective for Hospital & Diagnostic
Laboratories by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for
Pharmaceutical & Biotechnology Companies by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 11: World 8-Year Perspective for Pharmaceutical &
Biotechnology Companies by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2023 & 2030
Table 12: World Recent Past, Current & Future Analysis for
Clinical by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR
Table 13: World 8-Year Perspective for Clinical by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2023 & 2030
Table 14: World Recent Past, Current & Future Analysis for
In-vitro Studies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 15: World 8-Year Perspective for In-vitro Studies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for
Luciferase Assays by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 17: World 8-Year Perspective for Luciferase Assays by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030
Table 18: World Recent Past, Current & Future Analysis for
Fluorescent Protein-Related Assays by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 19: World 8-Year Perspective for Fluorescent
Protein-Related Assays by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2023 & 2030
Table 20: World Recent Past, Current & Future Analysis for
Chloramphenicol Acetyltransferase Assays by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 21: World 8-Year Perspective for Chloramphenicol
Acetyltransferase Assays by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2023 & 2030
Table 22: World Recent Past, Current & Future Analysis for
Beta-Galactosidase Assays by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 23: World 8-Year Perspective for Beta-Galactosidase
Assays by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2023 & 2030
Table 24: World Recent Past, Current & Future Analysis for
Beta-Glucuronidase Assays by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 25: World 8-Year Perspective for Beta-Glucuronidase
Assays by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2023 & 2030
Table 26: World Recent Past, Current & Future Analysis for
Other Assays by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR
Table 27: World 8-Year Perspective for Other Assays by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
Reporter Gene Assay Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 28: USA Recent Past, Current & Future Analysis for
Reporter Gene Assay by Product Type - Luciferase Assays,
Fluorescent Protein-Related Assays, Chloramphenicol
Acetyltransferase Assays, Beta-Galactosidase Assays,
Beta-Glucuronidase Assays and Other Assays - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 29: USA 8-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for
Luciferase Assays, Fluorescent Protein-Related Assays,
Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase
Assays, Beta-Glucuronidase Assays and Other Assays for the
Years 2023 & 2030
Table 30: USA Recent Past, Current & Future Analysis for
Reporter Gene Assay by End-Use - Contract Research
Organizations (CROs), Academic & Research Institutes, Hospital &
Diagnostic Laboratories and Pharmaceutical & Biotechnology
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 31: USA 8-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations (CROs), Academic & Research Institutes,
Hospital & Diagnostic Laboratories and Pharmaceutical &
Biotechnology Companies for the Years 2023 & 2030
Table 32: USA Recent Past, Current & Future Analysis for
Reporter Gene Assay by Application - Clinical and In-vitro
Studies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 33: USA 8-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Clinical
and In-vitro Studies for the Years 2023 & 2030
CANADA
Table 34: Canada Recent Past, Current & Future Analysis for
Reporter Gene Assay by Product Type - Luciferase Assays,
Fluorescent Protein-Related Assays, Chloramphenicol
Acetyltransferase Assays, Beta-Galactosidase Assays,
Beta-Glucuronidase Assays and Other Assays - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 35: Canada 8-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for
Luciferase Assays, Fluorescent Protein-Related Assays,
Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase
Assays, Beta-Glucuronidase Assays and Other Assays for the
Years 2023 & 2030
Table 36: Canada Recent Past, Current & Future Analysis for
Reporter Gene Assay by End-Use - Contract Research
Organizations (CROs), Academic & Research Institutes, Hospital &
Diagnostic Laboratories and Pharmaceutical & Biotechnology
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 37: Canada 8-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations (CROs), Academic & Research Institutes,
Hospital & Diagnostic Laboratories and Pharmaceutical &
Biotechnology Companies for the Years 2023 & 2030
Table 38: Canada Recent Past, Current & Future Analysis for
Reporter Gene Assay by Application - Clinical and In-vitro
Studies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 39: Canada 8-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Clinical
and In-vitro Studies for the Years 2023 & 2030
JAPAN
Reporter Gene Assay Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 40: Japan Recent Past, Current & Future Analysis for
Reporter Gene Assay by Product Type - Luciferase Assays,
Fluorescent Protein-Related Assays, Chloramphenicol
Acetyltransferase Assays, Beta-Galactosidase Assays,
Beta-Glucuronidase Assays and Other Assays - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 41: Japan 8-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for
Luciferase Assays, Fluorescent Protein-Related Assays,
Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase
Assays, Beta-Glucuronidase Assays and Other Assays for the
Years 2023 & 2030
Table 42: Japan Recent Past, Current & Future Analysis for
Reporter Gene Assay by End-Use - Contract Research
Organizations (CROs), Academic & Research Institutes, Hospital &
Diagnostic Laboratories and Pharmaceutical & Biotechnology
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 43: Japan 8-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations (CROs), Academic & Research Institutes,
Hospital & Diagnostic Laboratories and Pharmaceutical &
Biotechnology Companies for the Years 2023 & 2030
Table 44: Japan Recent Past, Current & Future Analysis for
Reporter Gene Assay by Application - Clinical and In-vitro
Studies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 45: Japan 8-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Clinical
and In-vitro Studies for the Years 2023 & 2030
CHINA
Reporter Gene Assay Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 46: China Recent Past, Current & Future Analysis for
Reporter Gene Assay by Product Type - Luciferase Assays,
Fluorescent Protein-Related Assays, Chloramphenicol
Acetyltransferase Assays, Beta-Galactosidase Assays,
Beta-Glucuronidase Assays and Other Assays - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 47: China 8-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for
Luciferase Assays, Fluorescent Protein-Related Assays,
Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase
Assays, Beta-Glucuronidase Assays and Other Assays for the
Years 2023 & 2030
Table 48: China Recent Past, Current & Future Analysis for
Reporter Gene Assay by End-Use - Contract Research
Organizations (CROs), Academic & Research Institutes, Hospital &
Diagnostic Laboratories and Pharmaceutical & Biotechnology
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 49: China 8-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations (CROs), Academic & Research Institutes,
Hospital & Diagnostic Laboratories and Pharmaceutical &
Biotechnology Companies for the Years 2023 & 2030
Table 50: China Recent Past, Current & Future Analysis for
Reporter Gene Assay by Application - Clinical and In-vitro
Studies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 51: China 8-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Clinical
and In-vitro Studies for the Years 2023 & 2030
EUROPE
Reporter Gene Assay Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 52: Europe Recent Past, Current & Future Analysis for
Reporter Gene Assay by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2022 through 2030 and %
CAGR
Table 53: Europe 8-Year Perspective for Reporter Gene Assay by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2023 & 2030
Table 54: Europe Recent Past, Current & Future Analysis for
Reporter Gene Assay by Product Type - Luciferase Assays,
Fluorescent Protein-Related Assays, Chloramphenicol
Acetyltransferase Assays, Beta-Galactosidase Assays,
Beta-Glucuronidase Assays and Other Assays - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 55: Europe 8-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for
Luciferase Assays, Fluorescent Protein-Related Assays,
Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase
Assays, Beta-Glucuronidase Assays and Other Assays for the
Years 2023 & 2030
Table 56: Europe Recent Past, Current & Future Analysis for
Reporter Gene Assay by End-Use - Contract Research
Organizations (CROs), Academic & Research Institutes, Hospital &
Diagnostic Laboratories and Pharmaceutical & Biotechnology
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 57: Europe 8-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations (CROs), Academic & Research Institutes,
Hospital & Diagnostic Laboratories and Pharmaceutical &
Biotechnology Companies for the Years 2023 & 2030
Table 58: Europe Recent Past, Current & Future Analysis for
Reporter Gene Assay by Application - Clinical and In-vitro
Studies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 59: Europe 8-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Clinical
and In-vitro Studies for the Years 2023 & 2030
FRANCE
Reporter Gene Assay Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 60: France Recent Past, Current & Future Analysis for
Reporter Gene Assay by Product Type - Luciferase Assays,
Fluorescent Protein-Related Assays, Chloramphenicol
Acetyltransferase Assays, Beta-Galactosidase Assays,
Beta-Glucuronidase Assays and Other Assays - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 61: France 8-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for
Luciferase Assays, Fluorescent Protein-Related Assays,
Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase
Assays, Beta-Glucuronidase Assays and Other Assays for the
Years 2023 & 2030
Table 62: France Recent Past, Current & Future Analysis for
Reporter Gene Assay by End-Use - Contract Research
Organizations (CROs), Academic & Research Institutes, Hospital &
Diagnostic Laboratories and Pharmaceutical & Biotechnology
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 63: France 8-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations (CROs), Academic & Research Institutes,
Hospital & Diagnostic Laboratories and Pharmaceutical &
Biotechnology Companies for the Years 2023 & 2030
Table 64: France Recent Past, Current & Future Analysis for
Reporter Gene Assay by Application - Clinical and In-vitro
Studies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 65: France 8-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Clinical
and In-vitro Studies for the Years 2023 & 2030
GERMANY
Reporter Gene Assay Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 66: Germany Recent Past, Current & Future Analysis for
Reporter Gene Assay by Product Type - Luciferase Assays,
Fluorescent Protein-Related Assays, Chloramphenicol
Acetyltransferase Assays, Beta-Galactosidase Assays,
Beta-Glucuronidase Assays and Other Assays - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 67: Germany 8-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for
Luciferase Assays, Fluorescent Protein-Related Assays,
Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase
Assays, Beta-Glucuronidase Assays and Other Assays for the
Years 2023 & 2030
Table 68: Germany Recent Past, Current & Future Analysis for
Reporter Gene Assay by End-Use - Contract Research
Organizations (CROs), Academic & Research Institutes, Hospital &
Diagnostic Laboratories and Pharmaceutical & Biotechnology
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 69: Germany 8-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations (CROs), Academic & Research Institutes,
Hospital & Diagnostic Laboratories and Pharmaceutical &
Biotechnology Companies for the Years 2023 & 2030
Table 70: Germany Recent Past, Current & Future Analysis for
Reporter Gene Assay by Application - Clinical and In-vitro
Studies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 71: Germany 8-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Clinical
and In-vitro Studies for the Years 2023 & 2030
ITALY
Table 72: Italy Recent Past, Current & Future Analysis for
Reporter Gene Assay by Product Type - Luciferase Assays,
Fluorescent Protein-Related Assays, Chloramphenicol
Acetyltransferase Assays, Beta-Galactosidase Assays,
Beta-Glucuronidase Assays and Other Assays - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 73: Italy 8-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for
Luciferase Assays, Fluorescent Protein-Related Assays,
Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase
Assays, Beta-Glucuronidase Assays and Other Assays for the
Years 2023 & 2030
Table 74: Italy Recent Past, Current & Future Analysis for
Reporter Gene Assay by End-Use - Contract Research
Organizations (CROs), Academic & Research Institutes, Hospital &
Diagnostic Laboratories and Pharmaceutical & Biotechnology
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 75: Italy 8-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations (CROs), Academic & Research Institutes,
Hospital & Diagnostic Laboratories and Pharmaceutical &
Biotechnology Companies for the Years 2023 & 2030
Table 76: Italy Recent Past, Current & Future Analysis for
Reporter Gene Assay by Application - Clinical and In-vitro
Studies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 77: Italy 8-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Clinical
and In-vitro Studies for the Years 2023 & 2030
UNITED KINGDOM
Reporter Gene Assay Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 78: UK Recent Past, Current & Future Analysis for
Reporter Gene Assay by Product Type - Luciferase Assays,
Fluorescent Protein-Related Assays, Chloramphenicol
Acetyltransferase Assays, Beta-Galactosidase Assays,
Beta-Glucuronidase Assays and Other Assays - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 79: UK 8-Year Perspective for Reporter Gene Assay by
Product Type - Percentage Breakdown of Value Sales for
Luciferase Assays, Fluorescent Protein-Related Assays,
Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase
Assays, Beta-Glucuronidase Assays and Other Assays for the
Years 2023 & 2030
Table 80: UK Recent Past, Current & Future Analysis for
Reporter Gene Assay by End-Use - Contract Research
Organizations (CROs), Academic & Research Institutes, Hospital &
Diagnostic Laboratories and Pharmaceutical & Biotechnology
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 81: UK 8-Year Perspective for Reporter Gene Assay by
End-Use - Percentage Breakdown of Value Sales for Contract
Research Organizations (CROs), Academic & Research Institutes,
Hospital & Diagnostic Laboratories and Pharmaceutical &
Biotechnology Companies for the Years 2023 & 2030
Table 82: UK Recent Past, Current & Future Analysis for
Reporter Gene Assay by Application - Clinical and In-vitro
Studies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 83: UK 8-Year Perspective for Reporter Gene Assay by
Application - Percentage Breakdown of Value Sales for Clinical
and In-vitro Studies for the Years 2023 & 2030
REST OF EUROPE
Table 84: Rest of Europe Recent Past, Current & Future Analysis
for Reporter Gene Assay by Product Type - Luciferase Assays,
Fluorescent Protein-Related Assays, Chloramphenicol
Acetyltransferase Assays, Beta-Galactosidase Assays,
Beta-Glucuronidase Assays and Other Assays - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 85: Rest of Europe 8-Year Perspective for Reporter Gene
Assay by Product Type - Percentage Breakdown of Value Sales for
Luciferase Assays, Fluorescent Protein-Related Assays,
Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase
Assays, Beta-Glucuronidase Assays and Other Assays for the
Years 2023 & 2030
Table 86: Rest of Europe Recent Past, Current & Future Analysis
for Reporter Gene Assay by End-Use - Contract Research
Organizations (CROs), Academic & Research Institutes, Hospital &
Diagnostic Laboratories and Pharmaceutical & Biotechnology
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 87: Rest of Europe 8-Year Perspective for Reporter Gene
Assay by End-Use - Percentage Breakdown of Value Sales for
Contract Research Organizations (CROs), Academic & Research
Institutes, Hospital & Diagnostic Laboratories and
Pharmaceutical & Biotechnology Companies for the Years 2023 &
2030
Table 88: Rest of Europe Recent Past, Current & Future Analysis
for Reporter Gene Assay by Application - Clinical and In-vitro
Studies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 89: Rest of Europe 8-Year Perspective for Reporter Gene
Assay by Application - Percentage Breakdown of Value Sales for
Clinical and In-vitro Studies for the Years 2023 & 2030
ASIA-PACIFIC
Reporter Gene Assay Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 90: Asia-Pacific Recent Past, Current & Future Analysis
for Reporter Gene Assay by Product Type - Luciferase Assays,
Fluorescent Protein-Related Assays, Chloramphenicol
Acetyltransferase Assays, Beta-Galactosidase Assays,
Beta-Glucuronidase Assays and Other Assays - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 91: Asia-Pacific 8-Year Perspective for Reporter Gene
Assay by Product Type - Percentage Breakdown of Value Sales for
Luciferase Assays, Fluorescent Protein-Related Assays,
Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase
Assays, Beta-Glucuronidase Assays and Other Assays for the
Years 2023 & 2030
Table 92: Asia-Pacific Recent Past, Current & Future Analysis
for Reporter Gene Assay by End-Use - Contract Research
Organizations (CROs), Academic & Research Institutes, Hospital &
Diagnostic Laboratories and Pharmaceutical & Biotechnology
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 93: Asia-Pacific 8-Year Perspective for Reporter Gene
Assay by End-Use - Percentage Breakdown of Value Sales for
Contract Research Organizations (CROs), Academic & Research
Institutes, Hospital & Diagnostic Laboratories and
Pharmaceutical & Biotechnology Companies for the Years 2023 &
2030
Table 94: Asia-Pacific Recent Past, Current & Future Analysis
for Reporter Gene Assay by Application - Clinical and In-vitro
Studies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 95: Asia-Pacific 8-Year Perspective for Reporter Gene
Assay by Application - Percentage Breakdown of Value Sales for
Clinical and In-vitro Studies for the Years 2023 & 2030
REST OF WORLD
Table 96: Rest of World Recent Past, Current & Future Analysis
for Reporter Gene Assay by Product Type - Luciferase Assays,
Fluorescent Protein-Related Assays, Chloramphenicol
Acetyltransferase Assays, Beta-Galactosidase Assays,
Beta-Glucuronidase Assays and Other Assays - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 97: Rest of World 8-Year Perspective for Reporter Gene
Assay by Product Type - Percentage Breakdown of Value Sales for
Luciferase Assays, Fluorescent Protein-Related Assays,
Chloramphenicol Acetyltransferase Assays, Beta-Galactosidase
Assays, Beta-Glucuronidase Assays and Other Assays for the
Years 2023 & 2030
Table 98: Rest of World Recent Past, Current & Future Analysis
for Reporter Gene Assay by End-Use - Contract Research
Organizations (CROs), Academic & Research Institutes, Hospital &
Diagnostic Laboratories and Pharmaceutical & Biotechnology
Companies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 99: Rest of World 8-Year Perspective for Reporter Gene
Assay by End-Use - Percentage Breakdown of Value Sales for
Contract Research Organizations (CROs), Academic & Research
Institutes, Hospital & Diagnostic Laboratories and
Pharmaceutical & Biotechnology Companies for the Years 2023 &
2030
Table 100: Rest of World Recent Past, Current & Future Analysis
for Reporter Gene Assay by Application - Clinical and In-vitro
Studies - Independent Analysis of Annual Sales in US$ Million
for the Years 2022 through 2030 and % CAGR
Table 101: Rest of World 8-Year Perspective for Reporter Gene
Assay by Application - Percentage Breakdown of Value Sales for
Clinical and In-vitro Studies for the Years 2023 & 2030
IV. COMPETITION
Read the full report: https://www.reportlinker.com/p06032765/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
